{"id":245842,"date":"2012-02-16T10:16:52","date_gmt":"2012-02-16T10:16:52","guid":{"rendered":"http:\/\/www.eugenesis.com\/protein-that-functions-in-normal-breast-may-also-contribute-to-breast-cancer-metastasis\/"},"modified":"2012-02-16T10:16:52","modified_gmt":"2012-02-16T10:16:52","slug":"protein-that-functions-in-normal-breast-may-also-contribute-to-breast-cancer-metastasis","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/protein-that-functions-in-normal-breast-may-also-contribute-to-breast-cancer-metastasis.php","title":{"rendered":"Protein that functions in normal breast may also contribute to breast cancer metastasis"},"content":{"rendered":"<p>Public  release date: 16-Feb-2012<br \/>  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: David Sampson<br \/>    <a href=\"mailto:ajpmedia@elsevier.com\">ajpmedia@elsevier.com<\/a><br \/>    215-239-3171<br \/>    Elsevier Health    Sciences  <\/p>\n<p>    Philadelphia, PA -- The trefoil factor 3 (TFF3) protein    protects and maintains the integrity of the epithelial surface    in the normal breast. New research has found that while TFF3    protein expression is higher in well-differentiated low grade    tumors and therefore associated with features of a good    prognosis, it has a more sinister role in breast cancer    invasion and metastasis. The report is published in the March    issue of the American Journal of Pathology.  <\/p>\n<p>    \"Our findings suggest that TFF3 is regulated by estrogen and    has beneficial properties in breast epithelia,\" says lead    investigator Felicity E.B. May, PhD, of the Northern Institute    for Cancer Research and the Department of Pathology at    Newcastle University, UK. \"We propose that early during breast    tumorigenesis, TFF3 retains its association with normal    functionality of breast epithelial cells. Subsequently, with    the loss of tumor cell differentiation, its function is    subverted to promote the development of tumors and infiltration    and lymph node metastasis.\"  <\/p>\n<p>    To determine the role of TFF3 in breast cancer, researchers    measured its level in tissue samples from normal breasts,    benign breast lesions, in situ carcinomas, invasive carcinomas,    and involved lymph nodes. TFF3 was expressed in the majority of    benign and malignant breast lesions studied.    Well-differentiated tumor types expressed higher levels of    TFF3. There was a positive association between TFF3 protein    expression and microvessel density, suggesting that it    stimulates angiogenesis in breast tumors.  <\/p>\n<p>    A striking finding of the study is the strength and consistency    of the association between TFF3 expression and a more    metastatic phenotype in invasive breast cancer. TFF3 was    expressed at higher levels in primary tumors with associated    metastasis, and its expression was higher in malignant cells    that have metastasized away from those within the primary    tumor. There appears to be a switch in the normal polarized    secretion of TFF3 in invasive cancer, which allows it to exert    invasion-promoting effects.  <\/p>\n<p>    The study suggests that TFF3 may be one of the genes that    mediate the various effects of estrogens in breast cancer. \"The    paradox remains, however, for both the estrogen receptor and    TFF3, that they contribute to the normal physiology of the    breast epithelium yet are involved in the progression of    cancer,\" notes Dr. May.  <\/p>\n<p>    Importantly, the investigators also evaluated the potential of    TFF3 as a biomarker of lymphovascular invasion and lymph node    metastasis. They found that TFF3 had greater predictive power    than other markers analyzed, including tumor grade, age, tumor    size and type, and estrogen and progesterone receptor status.    \"Our study reinforces the view that TFF3 expression merits    evaluation as a prognostic biomarker and as a predictive marker    of response to therapy,\" concludes Dr. May. \"It is probable    that its malign effects will be mitigated by adjuvant endocrine    therapy in women with hormone-responsive cancers. However, the    usefulness of TFF3 as a marker of hormone responsiveness needs    to be evaluated.\"  <\/p>\n<p>    ###  <\/p>\n<p>    The article is \"TFF3 Is a Normal Breast Epithelial Protein and    Is Associated with Differentiated Phenotype in Early Breast    Cancer but Predisposes to Invasion and Metastasis in Advanced    Disease,\" by A.R.H. Ahmed, A.B. Griffiths, M.T. Tilby, B.R.    Westley, and F.E.B. May (doi: 10.1016\/j.ajpath.2011.11.022). It    will appear in The American Journal of Pathology, Volume    180, Issue 3 (March 2012) published by Elsevier.  <\/p>\n<p><br clear=\"both\">     [ |   E-mail   |  Share    ]  <\/p>\n<p>    &nbsp;  <\/p>\n<p class=\"disclaimer\">    AAAS and EurekAlert! are not responsible for the accuracy    of news releases posted to EurekAlert! by contributing    institutions or for the use of any information through the    EurekAlert! system.  <\/p>\n<p><\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-02\/ehs-ptf020912.php\" title=\"Protein that functions in normal breast may also contribute to breast cancer metastasis\">Protein that functions in normal breast may also contribute to breast cancer metastasis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Public release date: 16-Feb-2012 [ | E-mail | Share ] Contact: David Sampson <a href=\"mailto:ajpmedia@elsevier.com\">ajpmedia@elsevier.com<\/a> 215-239-3171 Elsevier Health Sciences Philadelphia, PA -- The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/protein-that-functions-in-normal-breast-may-also-contribute-to-breast-cancer-metastasis.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245842","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245842"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245842"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}